Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.news

Allergy Named Highest-Impact Journal in Allergy and Clinical Immunology for 2024

Allergy , one of EAACI's official journals, has been recognised as the highest-impact journal in the field of Allergy and Clinical Immunology for 2024. According to Journal Impact Factors released by Clarivate, Allergy boasts an impressive Impact Factor of 12.6, securing its position as the number one journal in its speciality.About Allergy Allergy is dedicated to advancing, impacting, and communicating all aspects of the discipline of Allergy and Immunology. The journal covers a...

IVD Contract Manufacturing Services Market to be Worth $25.80 Billion by 2031 -…

IVD contract manufacturing services allow organizations to outsource manufacturing processes. Companies outsource a product or a part of a product. This is often used to increase production rates or to expand product offerings without investing in new equipment and machinery. IVD contract manufacturing services allow organizations to outsource manufacturing processes. Companies outsource a product or a part of a product. This is often used to increase production rates or to expand product...

HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small…

The Phase Ib trial of HDM1002 in China was a randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple-dose, escalating oral administrations of HDM1002 in overweight and obese adult subjects. Total 60 subjects were enrolled. After 28 days of continuous dosing within the dose range of 50-400mg, HDM1002 demonstrated good safety and tolerability. The most common adverse events were gastrointestinal-related, mostly mild…

Major shareholder announcement

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis, that as of June 21, BlackRock, Inc. crossed the 5% threshold regarding issued share capital in Novozymes A/S, part of Novonesis Group.Attachments 2024_24_Major_Shareholders_AnnouncementNovozymes B 21 June 2024 Final

Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient

ePatient is set to transform the patient experience by unifying payments, appointments, reminders, and eCOA questionnaires into a single user-friendly mobile interface with the simple, intuitive design Suvoda is known for. The application's seamless integration with Suvoda's IRT and eConsent ensures a cohesive user experience, enabling site users and patients to move effortlessly between all Suvoda products with a single sign-on. ePatient is set to transform the patient experience by unifying...

SyMRI 15 by SyntheticMR obtains CE-Marking

SyMRI 15 has been clinically proven and validated in a large multi-center study across several high-profile institutes in the United States. The results of the clinical study showed that SyMRI 3D can replace conventional 3D images, enhancing both efficiency and throughput. This is in addition to its established capabilities in providing quantitative values and tissue segmentation. The findings reinforce its diagnostic accuracy, instilling confidence in SyMRI users to substitute conventional 3D…

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel…

Positive Feedback Received:An International Preliminary Report on Patentability (IPRP) indicates promising prospects for obtaining granted patents and protecting the invention Unique Attributes and Inventiveness:The feedback highlights the distinct and inventive nature of all relevant claims in the application, distinguishing the invention in the field of personalized cancer vaccinesStrengthened Position : The patentability report reinforces Evaxion's strong stance in the...

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease…

Howard L. Weiner, M.D., Principal Investigator, Chairman of Tiziana's Scientific Advisory Board and co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital, a founding member of Mass General Brigham healthcare system stated, “I am excited to treat this first patient with moderate AD with nasal foralumab as early as July. These patients have no other treatment options including newly approved anti-amyloid drugs and continue to deteriorate. Given that...

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

New executive appointment made ahead of pivotal study results, potential regulatory approval and subsequent commercialization of investigational COMP360 psilocybin treatmentLatest of several key executive team hires, rounding out team to take Compass through phase 3 and beyondLONDON, June26, 2024(GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today...

ADOLFO DOMÍNGUEZ PRESENTS HIS NEW FASHION AND FRAGRANCE COLLECTION AT A WORLD…

MADRID, June 26, 2024 /PRNewswire/ -- Adolfo Domínguez keeps moving forward in its commitment to bring fashion closer to society. The brand will showcase Ikigai, its autumn-winter 2024 collection, together with a selection of new perfumes in a global fashion show. MADRID , June 26, 2024 /PRNewswire/ -- Adolfo Domínguez keeps moving forward in its commitment to bring fashion closer to society. The brand will showcase Ikigai, its autumn-winter 2024 collection, together with a selection of...

Alvotech Receives Conversion Notices for Majority of Convertible Bonds

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that holders of the majority of subordinated convertible bonds, originally issued by Alvotech on November 16, 2022, and December 20, 2022, respectively, with maturity on December 20, 2025 (the “Convertible Bonds”) have elected to convert the principal and accrued interest into ordinary shares of Alvotech at the fixed conversion price of…

Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya…

Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older is now underway in both the EU and in the U.S.COPENHAGEN, Denmark, June 26, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval of the Company's vaccine candidate for immunization to prevent...

Saw Palmetto Berries Market to Reach $325.6 Million, Globally, by 2035 at 5.6%…

Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A32241 Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A32241 Prime determinants of growth One of the major drivers in the saw palmetto berries market is primarily driven by increasing awareness about the health benefits of saw palmetto berries, particularly in promoting prostate health and managing urinary symptoms, fuels demand. Moreover, rising consumer preference for natural...

Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study…

Landmark RAMPART study established midazolam intramuscular (IM) injection as a standard of care in the pre-hospital emergency management of epilepsy crises compared to traditional benzodiazepine intravenous (IV)Crossject's bioequivalence study, recently published inNeurology and Therapy, remarkably consistent with RAMPART's findings and authors' viewsDijon, France 26 June, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company in advanced phases of...

ONWARD® Medical Announces Participation in Stifel European Healthcare Summit

CEO Dave Marver will meet with investors to discuss the Company's achievements and upcoming milestones th. CEO Dave Marver will meet with current and potential ONWARD Medical investors from leading European specialist and generalist funds.To learn more about ONWARD Medical's commitment to partnering with the SCI Community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury, please visitONWD.com. *All ONWARD ®Medical...

dsm-firmenich issues €800 million long-term bond

The terms are laid down in the €8 billion Debt Issuance Program of dsm-firmenich alongside the Final Terms of this issuance, both of which are available here. The terms are laid down in the €8 billion Debt Issuance Program of dsm-firmenich alongside the Final Terms of this issuance, both of which are availablehere. The re-offer price for the ten-year bond tranche was 99.456%. Based on this price, the yield is 3.691%. The bonds will shortly be listed on the Luxembourg Stock Exchange...

Apollo Cancer Centres Collaborates With Accuray to Launch India Sub- Continent's…

Dr Sridhar PS, Lead- Cyberknife – Robotic Radiosurgery, said, "The launch of the training program at Apollo Cancer Centre is an exceptional opportunity to enhance skills and knowledge in Robotic & Stereotactic Radiotherapy . Since pioneering the Cyberknife Robotic Radio Surgery System in India and a rich experience of over 5000 patients, we will now share the valuable knowledge in the training program. It will enable oncologists in the development of Cancer care through Cyberknife…

Zealand Pharma announces completion of an upsized equity offering of 8.35…

Company announcement – No. 35 / 2024Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN THE UNITED...

Corneal Ulcer Market to Increase at a Steady Growth Rate During the Study Period…

Key Takeaways from the Corneal Ulcer Market Report Key Takeaways from the Corneal Ulcer Market Report Discover which therapies are expected to grab the major corneal ulcer market share @Corneal Ulcer Market Report Corneal Ulcer Overview A corneal ulcer is a serious condition characterized by an open sore on the cornea, the clear, dome-shaped surface that covers the front of the eye. This ulcer can result from various causes, including bacterial, viral, fungal, or parasitic...

Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel…

"This is an exciting time at Skyhawk," said Clint Musil, Chief Executive Officer of Skyhawk Therapeutics. "With our first program for Huntington's disease progressing in the clinic and our second program, SKY-1214, on track to enter the clinic, we've doubled our lab space in Basel to drive a series of promising INDs. Superlab Suisse is a leading provider of innovative research space and the largest private lab space in Switzerland, with a mission to provide dynamic infrastructure…

Zealand Pharma announces upsizing of previously announced equity offering from…

Company announcement – No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billionNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN THE...

Allergy Named Highest-Impact Journal in Allergy and Clinical Immunology for 2024

Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment…

Urinalysis Market Worth USD 6.8 Billion by 2029: Growth Drivers, Key Players…

Blockchain Technology in Healthcare Market: Security Demand Propels Growth to…

IVD Contract Manufacturing Services Market to be Worth $25.80 Billion by 2031 -…

HUADONG MEDICINE Announces Positive Phase I Results for Innovative Oral Small…

Major shareholder announcement

Suvoda Expands its Clinical Trial Offering with the Introduction of ePatient

SyMRI 15 by SyntheticMR obtains CE-Marking

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel…

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease…

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

ADOLFO DOMÍNGUEZ PRESENTS HIS NEW FASHION AND FRAGRANCE COLLECTION AT A WORLD…

Alvotech Receives Conversion Notices for Majority of Convertible Bonds

Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya…

Saw Palmetto Berries Market to Reach $325.6 Million, Globally, by 2035 at 5.6%…

Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study…

ONWARD® Medical Announces Participation in Stifel European Healthcare Summit

dsm-firmenich issues €800 million long-term bond

Apollo Cancer Centres Collaborates With Accuray to Launch India Sub- Continent's…

Zealand Pharma announces completion of an upsized equity offering of 8.35…

Corneal Ulcer Market to Increase at a Steady Growth Rate During the Study Period…

Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel…

Zealand Pharma announces upsizing of previously announced equity offering from…